Table 1.
Characteristics of the study participants
| HIV+METH+ (n=16) | HIV+METH− (n=11) | HIV−METH− (n=30) | p-value* | |
|---|---|---|---|---|
| Ethnicity (Hisp:Not Hisp) | 2:14 | 2:9 | 8:22 | 0.57 |
| Age | 50.2±8.1 | 46.1±7.5 | 51.4±12.1 | 0.32 |
| CSF HIV RNA Levels (log10 copies/mL) | 1.73±0.86 | 2.21±1.34 | - | 0.17 |
| Proportion of undetectability HIV RNA in CSF (<50 copies) | 3/13 | 3/8 | - | 0.66 |
| Plasma HIV RNA Levels (log10 copies/mL) | 3.36±1.52 | 3.27±2.30 | - | 0.64 |
| Proportion of undetectability HIV RNA in plasma (<50 copies) | 2/14 | 2/9 | - | 1 |
| CD4 Absolute Counts | 117±140 | 153±231 | - | 0.40 |
| GDS | 1.03±1.07 | 0.97±0.73 | - | 0.60 |
Mean values are shown for each study group.
*
Represent the p-value of a double-tailed Mann-Whitney or a Fisher test. See “Methods” section for the definitions of HIV+METH+, HIV+METH−, HIV−METH−.
Abbreviations: Hisp, Hispanic; CSF, cerebral spinal fluid; GDS, global deficit score.